After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q1 2024 call → NOThe question asks whether management reports that the most important positive developments happened so late in the period or shortly after it ended that the results contain little or none of their effect, with management itself marking the timing. Let me analyze the transcript for both halves: (1) LATE-BREAKING, CONCRETE POSITIVE EVENTS: - RECELL GO approval: The 180-day FDA review ends May 30, 2024. Management says "Assuming approval, our top 28 burn accounts will be prioritized for conversion to RECELL GO in June." This is still contingent on approval - not yet obtained. - CE mark for RECELL GO: "on April 22, 2024, the notified body confirmed that the technical document completeness check identified that all required information has been provided" - this is after quarter-end (Q1 ended March 31), and it's a step in the process, not final approval. Expected between September and December. - PermeaDerm launch: "we launched in the U.S. on March 23" - this is near the end of Q1. But it's described as "less than 1%" of revenue. - The 46 VAC approvals expected in Q2 - these are expected, not yet obtained. (2) MANAGEMENT TREATS THEM AS THE REAL STORY THE NUMBERS MISSED: - Management does discuss RECELL GO as transformative: "RECELL GO is going to transform our business model very fundamentally." But this is still pending approval. - The PermeaDerm launch on March 23 is late in the quarter, but management doesn't really frame it as "the real story the numbers missed" - it's less than 1% of revenue. Let me look more carefully. The question asks about "the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period." The PermeaDerm launch on March 23 is a concrete event that happened late in the quarter. But management doesn't frame it as the story the numbers missed - they acknowledge it's less than 1% of revenue. RECELL GO approval is still pending - it's contingent on FDA approval, which hasn't happened yet. The 180-day period ends May 30, but approval is not yet obtained. So this is still contingent. The CE mark progress on April 22 is after quarter-end, but it's a step in the process, not final approval, and it's for international expansion which is still in early stages. Management's main explanation for the weak quarter is: 1. Slower conversion of new accounts for full-thickness skin defects 2.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...